To provide Ebola vaccines to vulnerable populations as soon as possible, "We need to agree on the design of clinical trials, and we need to collaborate across borders to fast-track scientific assessment, regulatory approval and roll-out," said Sarah Barber, WHO representative in South Africa, in the